Summary
Updated Aug 30, 2026
Mark Germain is Director of Scinai Immunotherapeutics Ltd. (SCNI). 1 SEC Form 4 filing on record, dated 18 June 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Mark Germain has reported, most recent first.
Most Active Insiders Right Now
Mark Germain has no co-filers on record, so these are insiders with the largest open-market activity across the market in the last 90 days.
- Insight Holdings Group, LLC - $174.75M of HNGE open-market activity in the last 90 days
- BVF PARTNERS L P - $173.67M of KYMR open-market activity in the last 90 days
- KL Pattern Holdings LP - $166.93M of PTRN open-market activity in the last 90 days
- Silver Lake Partners V DE (AIV), L.P. - $165.05M of DELL open-market activity in the last 90 days
- Jack Jiajia Huang - $160.23M of COE open-market activity in the last 90 days
- GIC Private Ltd - $158.25M of MDLN open-market activity in the last 90 days
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Mark Germain?
Mark Germain is a corporate insider, tracked as Director of Scinai Immunotherapeutics Ltd. (SCNI). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Mark Germain submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Mark Germain's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Mark Germain and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
